Your search returned 3 results.

Results
	1.	An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. [electronic resource] by Queiroz-Telles, Flavio Goldani, Luciano Z Schlamm, Haran T Goodrich, James M Espinel-Ingroff, Ana Shikanai-Yasuda, Maria A Producer: 20071213 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Impact of baseline antiretroviral resistance status on efficacy outcomes among patients receiving maraviroc plus optimized background therapy in the MOTIVATE 1 and 2 trials. [electronic resource] by Nelson, Mark Fisher, Martin Gonzalez-Garcia, Juan Rockstroh, Jürgen K Weinstein, David Valdez, Hernan Mayer, Howard van der Ryst, Elna Goodrich, James M Dang, Nathalie Producer: 20101012 In: HIV clinical trials vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. [electronic resource] by Fleishaker, Dona L Garcia Meijide, Juan A Petrov, Andriy Kohen, Michael David Wang, Xin Menon, Sujatha Stock, Thomas C Mebus, Charles A Goodrich, James M Mayer, Howard B Zeiher, Bernhardt G Producer: 20121217 In: Arthritis research & therapy vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)